HBEGF Recombinant Antibody, PE-Cy5 Conjugated
Product Specifications
Background
Growth factor that mediates its effects via EGFR, ERBB2 and ERBB4. Required for normal cardiac valve formation and normal heart function. Promotes smooth muscle cell proliferation. May be involved in macrophage-mediated cellular proliferation. It is mitogenic for fibroblasts, but not endothelial cells. It is able to bind EGF receptor/EGFR with higher affinity than EGF itself and is a far more potent mitogen for smooth muscle cells than EGF. Also acts as a diphtheria toxin receptor.
Synonyms
DTR; DTS; DTSF; HB-EGF; HBEGF; HEGFL.
Gene ID
1839
Swiss Prot
Q99075
Cellular Locus
Secreted, Cell membrane
Host
Rabbit
Cross Reactivity
Human, Rat
Target
HBEGF
Clonality
Recombinant
Isotype
IgG
Conjugation
PE-Cy5
Source
KLH conjugated synthetic peptide derived from human HB EGF
Applications
WB
Purification
Purified by Protein A.
Excitation Emission
488nm/670nm
Concentration
Lot dependent
Dilution
WB (1:300-5000)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Gene ID URL
1839
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6137463-01 0.1 mL
Lunatic Fringe Homolog (LFNG, 3-beta-N-acetylglucosaminyltransferase, Beta-1,3-N-acetylglucosaminyltransferase Lunatic Fringe, O-Fucosylpeptide, SCDO3, EC 2.4.1.222) APC
Ask
View Details MBS6137463-02 5x 0.1 mL
Lunatic Fringe Homolog (LFNG, 3-beta-N-acetylglucosaminyltransferase, Beta-1,3-N-acetylglucosaminyltransferase Lunatic Fringe, O-Fucosylpeptide, SCDO3, EC 2.4.1.222) APC
Ask
View Details